InnAccel launches portable neonatal CPAP device for infants with RDS

InnAccel recently launched SAANS, world’s first portable, neonatal CPAP system. It can provide breathing support to critically ill neonates with Respiratory Distress Syndrome (RDS). Coeo Labs, a division of InnAccel, develop the innovative device

SAANS, requires minimal skill to use, and could help lessen one of India’s major causes of infant mortality. The device was conceptualized in collaboration with Dr Kristian Olson and Dr. Data Santorino of the Consortium of Affordable Medical Technologies (CAMTech).

Siraj Dhanani, Founder, CEO, InnAccel Technologies, said, “One-third of neonatal deaths occur while the infants with RDS are being transported to an NICU. In rural areas with limited facilities, many babies do not even get the opportunity to receive CPAP treatment. In addition, CPAP devices are designed only for use in the NICU. We wanted to address this gap with SAANS, which is an India-specific solution that resolves this critical issue of non-availability of CPAP in non-NICU settings and during transport to a NICU.”

SAANS has received multiple Indian and international awards including American Society of Mechanical Engineers Global iShow Finalist (2017), 3M Young Innovator award (2016), FICCI Healthcare award (2015), and the Tata Social Enterprise award (2015).

LEAVE A REPLY

Please enter your comment!
Please enter your name here